Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China
· Delayed Price · Currency is CNY 12.90
0.00 (0.00%)
Jun 20, 2025, 3:04 PM CST
Cachet Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 21,220 | 23,985 | 29,923 | 26,220 | 25,626 | 23,256 | Upgrade
|
| Other Revenue | 33.96 | 33.96 | 73.25 | - | - | - | Upgrade
|
| Revenue | 21,254 | 24,019 | 29,996 | 26,220 | 25,626 | 23,256 | Upgrade
|
| Revenue Growth (YoY) | -30.73% | -19.93% | 14.40% | 2.32% | 10.19% | 4.82% | Upgrade
|
| Cost of Revenue | 19,768 | 22,431 | 28,077 | 24,116 | 23,493 | 21,178 | Upgrade
|
| Gross Profit | 1,485 | 1,588 | 1,919 | 2,104 | 2,133 | 2,078 | Upgrade
|
| Selling, General & Admin | 801.32 | 882.78 | 1,052 | 1,153 | 1,088 | 915.23 | Upgrade
|
| Other Operating Expenses | 50.82 | 48.43 | 50.63 | 45.8 | 44.73 | 40.27 | Upgrade
|
| Operating Expenses | 972.12 | 1,026 | 1,186 | 1,273 | 1,159 | 997.23 | Upgrade
|
| Operating Income | 513.37 | 561.8 | 733.78 | 831 | 973.49 | 1,081 | Upgrade
|
| Interest Expense | -120.18 | -129.18 | -166.35 | -188.57 | -164.24 | -180.8 | Upgrade
|
| Interest & Investment Income | 19.24 | 19.48 | 31.12 | 22.43 | 18.66 | 20.16 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.21 | -0.21 | 0.57 | 0.18 | -0.66 | -0.37 | Upgrade
|
| Other Non Operating Income (Expenses) | -38.21 | -27.14 | -30.13 | -30.96 | -12.17 | -32.26 | Upgrade
|
| EBT Excluding Unusual Items | 374.01 | 424.74 | 568.99 | 634.08 | 815.08 | 887.48 | Upgrade
|
| Impairment of Goodwill | -80.41 | -80.41 | -40.05 | -20.21 | -13.71 | -76.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.33 | 0.04 | -3.5 | -2.63 | -0.52 | -9.79 | Upgrade
|
| Gain (Loss) on Sale of Assets | 201.26 | 201.43 | 0.85 | 1.67 | 0.74 | 1.28 | Upgrade
|
| Asset Writedown | -9.6 | -6.14 | -0.3 | -1.88 | -0.21 | -0.15 | Upgrade
|
| Other Unusual Items | 13.18 | 12.01 | 29.29 | 33.88 | 22.59 | 11.78 | Upgrade
|
| Pretax Income | 498.11 | 551.66 | 555.28 | 644.91 | 823.98 | 814.31 | Upgrade
|
| Income Tax Expense | 218.66 | 229.99 | 178.75 | 176.59 | 222.1 | 223.4 | Upgrade
|
| Earnings From Continuing Operations | 279.45 | 321.67 | 376.53 | 468.31 | 601.88 | 590.9 | Upgrade
|
| Minority Interest in Earnings | -148.17 | -161.01 | -126.47 | -171.38 | -248 | -273.32 | Upgrade
|
| Net Income | 131.28 | 160.67 | 250.06 | 296.94 | 353.88 | 317.59 | Upgrade
|
| Net Income to Common | 131.28 | 160.67 | 250.06 | 296.94 | 353.88 | 317.59 | Upgrade
|
| Net Income Growth | -49.09% | -35.75% | -15.79% | -16.09% | 11.43% | -15.53% | Upgrade
|
| Shares Outstanding (Basic) | 292 | 292 | 291 | 291 | 292 | 291 | Upgrade
|
| Shares Outstanding (Diluted) | 292 | 292 | 291 | 291 | 292 | 291 | Upgrade
|
| Shares Change (YoY) | 0.39% | 0.47% | -0.12% | -0.46% | 0.38% | 11.60% | Upgrade
|
| EPS (Basic) | 0.45 | 0.55 | 0.86 | 1.02 | 1.21 | 1.09 | Upgrade
|
| EPS (Diluted) | 0.45 | 0.55 | 0.86 | 1.02 | 1.21 | 1.09 | Upgrade
|
| EPS Growth | -49.29% | -36.05% | -15.69% | -15.70% | 11.01% | -24.31% | Upgrade
|
| Free Cash Flow | -152.89 | 164.93 | 1,396 | -351.98 | 666.17 | 856.88 | Upgrade
|
| Free Cash Flow Per Share | -0.52 | 0.56 | 4.80 | -1.21 | 2.28 | 2.94 | Upgrade
|
| Dividend Per Share | 0.170 | 0.170 | 0.260 | 0.310 | 0.370 | 0.330 | Upgrade
|
| Dividend Growth | -34.62% | -34.62% | -16.13% | -16.22% | 12.12% | -17.50% | Upgrade
|
| Gross Margin | 6.99% | 6.61% | 6.40% | 8.03% | 8.32% | 8.94% | Upgrade
|
| Operating Margin | 2.42% | 2.34% | 2.45% | 3.17% | 3.80% | 4.65% | Upgrade
|
| Profit Margin | 0.62% | 0.67% | 0.83% | 1.13% | 1.38% | 1.37% | Upgrade
|
| Free Cash Flow Margin | -0.72% | 0.69% | 4.65% | -1.34% | 2.60% | 3.69% | Upgrade
|
| EBITDA | 544.22 | 613.16 | 867.17 | 989.04 | 1,114 | 1,208 | Upgrade
|
| EBITDA Margin | 2.56% | 2.55% | 2.89% | 3.77% | 4.35% | 5.19% | Upgrade
|
| D&A For EBITDA | 30.86 | 51.36 | 133.39 | 158.03 | 140.26 | 127.12 | Upgrade
|
| EBIT | 513.37 | 561.8 | 733.78 | 831 | 973.49 | 1,081 | Upgrade
|
| EBIT Margin | 2.42% | 2.34% | 2.45% | 3.17% | 3.80% | 4.65% | Upgrade
|
| Effective Tax Rate | 43.90% | 41.69% | 32.19% | 27.38% | 26.96% | 27.43% | Upgrade
|
| Revenue as Reported | 21,254 | 24,019 | 29,996 | 26,220 | 25,626 | 23,256 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.